Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers
Abstract: Introduction: The expression of T-cell-associated antigens on diffuse large B-cell lymphoma (DLBCL) is uncommon. The coexpression of ≥2 T-cell-associated antigens on DLBCL is even rarer. This has been reported in the literature only a few times, most commonly coexpression of either CD5 or CD8 and a second, different T-cell marker. Case Presentation: This case report features a patient who presented with a rapidly evolving head and neck mass that displayed coexpression of CD5 and CD8. Conclusion: In this case report, we present the first case to our knowledge of DLBCL with coexpression of only CD5 and CD8.
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Diffuse Large B-Cell Lymphoma with Aberrant Coexpression of CD5 and CD8 T-Cell Markers ; volume:17 ; number:1 ; year:2024 ; pages:517-523 ; extent:7
Case reports in oncology ; 17, Heft 1 (2024), 517-523 (gesamt 7)
- Creator
-
Fan, Janet
Thanedar, Sarita
Ovechko, Vasily
Jana, Bagi
- DOI
-
10.1159/000536571
- URN
-
urn:nbn:de:101:1-2406270105010.442249802336
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:51 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fan, Janet
- Thanedar, Sarita
- Ovechko, Vasily
- Jana, Bagi
Other Objects (12)
Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
Mouse models for aberrant NF-kB activation in B-cell development and lymphomagenesis
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles
Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Single-cell Co-expression Subnetwork Analysis
IGFBP 1 increases β‐cell regeneration by promoting α‐ to β‐cell transdifferentiation
Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
Mouse models for aberrant NF-kB activation in B-cell development and lymphomagenesis
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles
Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Single-cell Co-expression Subnetwork Analysis
IGFBP 1 increases β‐cell regeneration by promoting α‐ to β‐cell transdifferentiation
Aberrant cell cycle regulatory ubiquitin networks in B-cell malignancies
Aberrant B-Cell Activation in Systemic Lupus Erythematosus
ALK-positive large B-cell lymphoma (ALK + LBCL) with aberrant CD3 expression
Phospho-specific flow cytometry identifies aberrant signaling in indolent B-cell lymphoma
Mouse models for aberrant NF-kB activation in B-cell development and lymphomagenesis
The immune synapses reveal aberrant functions of CD8 T cells during chronic HIV infection
How we treat mature B-cell neoplasms (indolent B-cell lymphomas)
Canine diffuse large B-cell lymphoma downregulates the activity of CD8 + T-cells through tumor-derived extracellular vesicles
Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Single-cell Co-expression Subnetwork Analysis